Google, Novartis Partner To Revolutionize HealthcareMark Melin
Google Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) and Swiss drugmaker Novartis AG (ADR) (NYSE:NVS) (VTX:NOVN) have announced an amazing development, one sure to be a significant point of differentiation in Google’s plans to beat Apple Inc. (NASDAQ:AAPL) and Samsung Electronics Co. Ltd. (LON:BC94) (KRX:0059935) in the race to control consumers healthcare applications.
The product under joint development is “smart” contact lenses that track blood glucose levels or . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.